Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues

1 day ago

Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over yearFull Year 2025 Revenue of…

VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery

1 day ago

SAN JOSE, CA / ACCESS Newswire / February 5, 2026 / VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth…

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging

1 day ago

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without…

Zomedica Announces “Fourth Friday at Four” Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline

1 day ago

February session to highlight how Zomedica's R&D strategy supports scalable growth and long-term shareholder value ANN ARBOR, MI / ACCESS…

Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

1 day ago

Virtual presentation scheduled for Thursday, February 26th at 12:40 PM ET Access the webcast here Carlsbad, CA, Feb. 05, 2026…

Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market

1 day ago

MELBOURNE, Australia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company…

Proven Senior Care Model Takes Center Stage at the Capitol

1 day ago

InnovAge PACE leaders and participants meet with lawmakers during critical budget yearDENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding…

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

1 day ago

Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026…

AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

1 day ago

Year-end report discusses combination therapy’s Mechanism of Action activating both innate and adaptive immune responsesOCALA, Fla., Feb. 05, 2026 (GLOBE…